Skip to main content
. 2017;31(2):130–142. doi: 10.7555/JBR.31.20160071

Tab.2.

Association of PM2.5 exposure with episodes of respiratory tract diseases in children and adult group.

N RR (95%CI) Random-effects P (I2) P for Egger / Begg bias test
Children Symptom
Wheezing 10 [18,19,23-25,30,32,33,35,39] 1.082 (1.011, 1.158) 0.000 (77.2%) 0.079 / 0.107
Bronchitis 5 [18,26,29-31] 1.145 (0.957, 1.370) 0.000 (90.2%) 0.593 / 1.000
Cough 10 [18-21,23,24,29,30,32,33] 1.075 (1.019, 1.134) 0.002 (65.4%) 0.007 / 0.721
Asthma 8 [18,27,34,38,40,41,47,48] 1.119 (0.989, 1.266) 0.000 (98.5%) 0.910 / 0.536
Lower respiratory illness 4 [18,19,21,36] 1.153 (1.033, 1.287) 0.006 (76.2%) 0.064 / 0.308
Respiratory infections 2 [22,30] 1.050 (0.930,1.184) 0.409 (0.00%) N/A / 1.000
Pneumonia 1 [46] 2.580 (0.910,7.270) - -
Total 40 1.104 (1.069, 1.139) 0.000 (95.4%) 0.025 / 0.408
Adult Symptom
Wheezing 4 [24,28,42,44] 1.053 (0.964, 1.150) 0.229 (30.5%) 0.593 / 1.000
Bronchitis 1 [44] 0.980 (0.860, 1.110) - -
Cough 4 [24,28,42,44] 0.951 (0.885, 1.021) 0.493 (0.00%) 0.713 / 0.308
Asthma 7 [27,28,37,42-45] 0.999 (0.978, 1.021) 0.553 (0.00%) 0.581 / 1.000
Lung cancer 4 [49,50,51,52] 1.064 (0.991, 1.142) 0.216 (30.8%) 0.691 / 0.806
Total 20 1.022 (0.986, 1.058) 0.000 (64.6%) 0.132 / 0.546

P (I2): P-value for test of heterogeneity, I2 of Higgins and Thompson reflecting the proportion of total variation in the estimate that is due to heterogeneity between studies. LRI: lower respiratory illness. Bold: significant results.